MDT perspectives on novel pharmacological and gene therapies for patients with DMD

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss novel pharmacological and gene therapies that are available or emerging for the management of DMD. The multidisciplinary team: Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/